Definium Therapeutics, Inc. (DFTX)
NASDAQ: DFTX · Real-Time Price · USD
32.02
-0.98 (-2.97%)
Nov 13, 2026, 10:01 AM EST - Market open
Definium Therapeutics Stock Forecast
Stock Price Forecast
According to 19 analysts polled by S&P Global, Definium Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $72.78. The average 1-year stock price forecast is 127.30% higher than the current stock price, while the lowest is $55 (+71.77%) and the highest is $91 (+184.20%).
Price Target: $72.78 (+127.30%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Definium Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 12 | 13 | 14 | 14 | 14 | 14 |
| Buy | 4 | 4 | 4 | 4 | 5 | 5 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 16 | 17 | 18 | 18 | 19 | 19 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JonesTrading | JonesTrading | Buy Reiterates $90 | Buy | Reiterates | $90 | +181.07% | Nov 12, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $72 | Buy | Maintains | $72 | +124.86% | Nov 11, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Nov 10, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $75 | Buy | Maintains | $75 | +134.23% | Nov 10, 2026 |
| Needham | Needham | Buy Reiterates $66 | Buy | Reiterates | $66 | +106.12% | Nov 10, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
31.44M
EPS This Year
-2.90
from -2.06
EPS Next Year
-1.82
from -2.90
EPS and Forward PE are based on non-GAAP adjusted numbers.